32.9 C
Vientiane
Sunday, September 7, 2025
spot_img
Home Blog Page 71

Asia Pacific View: Beijing Rediscovered–Where Heritage Meets Innovation, Openness Fuels the Future

BEIJING, Aug. 30, 2025 /PRNewswire/ — Beijing, an ancient capital steeped in profound historical legacy, is radiating its distinctive charm to the world with a revitalized presence. From the storied grandeur of the Forbidden City to the vibrant intangible cultural heritage at Qianmen Night Market, and from the industrial relics of Shougang Park to the fashionable trends of Sanlitun, Beijing masterfully balances tradition and innovation. These new discoveries not only enrich the city’s essence but also allow its historical and cultural roots to remain vibrant in modern life.

As China’s capital, Beijing boasts a robust infrastructure and public service system. Efficient transportation, diverse shopping destinations, and top-tier medical resources create a comfortable and convenient living environment for residents.

One of China’s premier tourist destinations, Beijing attracts numerous domestic and international visitors each year. Home to various art institutions and exhibition spaces, it has gathered many artists and creative talents, fostering a vibrant environment for artistic innovation.

As a hub for international exchange in China, Beijing embodies remarkable openness and inclusivity. Hosting embassies, international organizations, and multinational corporations from around the globe, it serves as a vital platform for global dialogue and connection.

Beijing is shaping a modern city committed to green, low-carbon living. Its green coverage has been significantly enhanced, while widespread access to shared bikes and low-carbon travel options add convenience for residents. The Urban Green Heart Forest Park has emerged as a popular destination for leisure and fitness.

In Beijing, the timeless vibrancy of traditional city life harmoniously blends with the dynamic pulse of a modern metropolis. From historical alleyways to chic commercial districts, and from low-carbon travel to smart elder care solutions, Beijing leverages refined urban management and human-centered services to create a livable city where “everyone participates and everyone benefits.”

Beijing’s new discoveries resonate with the echoes of history while heralding a brighter future. Embracing an open and inclusive spirit, fueled by innovative development, and committed to low-carbon and sustainable practices, the city is writing a magnificent chapter for a new era.

Experience Beijing’s charm through a captivating music video!

ZTO Express Announces Completion of the Repurchase Right Offer for Its 1.50% Convertible Senior Notes due 2027

SHANGHAI, Aug. 30, 2025 /PRNewswire/ — ZTO Express (Cayman) Inc. (NYSE: ZTO and HKEX: 2057), a leading and fast-growing express delivery company in China (“ZTO” or the “Company”), today announced that it has completed its previously announced repurchase right offer relating to its 1.50% Convertible Senior Notes due 2027 (CUSIP No. 98980AAB1) (the “Notes”). The repurchase right offer expired at 5:00 p.m., New York City time, on Thursday, August 28, 2025. Based on information from Citibank, N.A., as the paying agent for the Notes, US$982,252,000 aggregate principal amount of the Notes (the “Repurchase Price”) were validly surrendered and not withdrawn prior to the expiration of the repurchase right offer. The Company has forwarded cash in payment of the Repurchase Price to the Paying Agent for distribution to the Holders that had validly exercised their Repurchase Right. Following settlement of the repurchase, US$17,748,000 aggregate principal amount of the Notes will remain outstanding and continue to be subject to the existing terms of the Indenture and the Notes.

Materials filed with the SEC will be available electronically without charge at the SEC’s website, http://www.sec.gov. Documents filed with the SEC may also be obtained without charge at the Company’s website, https://zto.investorroom.com.

About ZTO Express (Cayman) Inc.

ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) (“ZTO” or the “Company”) is a leading and fast-growing express delivery company in China. ZTO provides express delivery service as well as other value-added logistics services through its extensive and reliable nationwide network coverage in China.

ZTO operates a highly scalable network partner model, which the Company believes is best suited to support the significant growth of e-commerce in China. The Company leverages its network partners to provide pickup and last-mile delivery services, while controlling the mission-critical line-haul transportation and sorting network within the express delivery service value chain.

For more information, please visit: https://zto.investorroom.com.

For investor and media inquiries, please contact:

ZTO Express (Cayman) Inc.

Investor Relations
E-mail: ir@zto.com
Phone: +86 21 5980 4508

Arzopa to Showcase Next-Generation Portable Displays and Digital Photo Frames at IFA 2025

NEW YORK, Aug. 30, 2025 /PRNewswire/ — Arzopa, a global innovator in digital display technology, will make its presence felt at IFA 2025 with a comprehensive lineup of new products that reflect the brand’s positioning as a premium, innovative, and reliable expert in portable imaging solutions. Visitors will discover how Arzopa blends lightweight aesthetics with intelligent interaction, redefining both mobile productivity and home visual experiences. (Hall 5.2, Booth 150)

At the heart of this year’s showcase is Arzopa’s latest generation of portable monitors, led by the ultra-slim Z3FC alongside the versatile E1 and E1S. The Z3FC combines portability with professional-grade performance, featuring a 16.1-inch display, 2.5K resolution, 180Hz refresh rate, and 100% sRGB color accuracy — making it ideal for gaming, streaming, and creative workflows that demand true-to-life visuals.

Complementing it, the Arzopa E1 (15.6″) and E1S (14″) dual-screen foldable monitors set a new benchmark for mobile productivity. A dual-gear hinge enables smooth 360-degree rotation with a near-gapless dual-screen view, while cascade, mirror, and extended modes adapt to diverse scenarios. With gravity-sensing auto-rotation, the E1 and E1S ensure seamless, professional content sharing and collaboration.

Expanding beyond displays, Arzopa will also unveil its new line of smart digital frames, including the D14, D14 Pro, and D16. Designed under the concept of “Frame Your Memories”, these large-format, high-definition frames transform photos and videos into stunning centerpieces for any living space. More than just a display, they double as thoughtful holiday gifts and elegant home décor, blending seamlessly with different interior styles thanks to their refined, versatile design.

Through these innovations, Arzopa continues to serve a diverse range of users — from gamers seeking smoother and sharper visuals, to business professionals balancing efficiency with design sophistication, and photographers and designers requiring accurate, portable color tools. Beyond productivity and creation, Arzopa also extends its vision into the home with smart digital frames that double as stylish décor and thoughtful gifts, helping families and friends stay connected through vivid displays of memories. Together, these offerings highlight the brand’s dedication to empowering lifestyles with technology that is both advanced and intuitive.

Arzopa will exhibit at IFA 2025, Hall 5.2, Booth 150, where media representatives are invited to experience the new portfolio first-hand. The company welcomes journalists for booth tours, in-depth product previews, and exclusive interviews.

About Arzopa

Founded in 2015, Arzopa specializes in innovative and accessible digital display solutions designed to enhance modern lifestyles. Its product portfolio spans portable monitors, smart frames, and visual accessories, each blending engineering precision with minimalist design to shape the future of visual technology.
Learn more at: www.arzopa.com

Media Contact:
 Olivia Wong
 PR Manager
 olivia@arzopa.com 

 

Arzopa IFA 2025
Arzopa IFA 2025

Rethink Light, Reimagine Style — Olight Unveils ArkPro Series with Groundbreaking Pure Flood

NEW YORK, Aug. 29, 2025 /PRNewswire/ — Olight, a global innovator in portable lighting, unveiled the ArkPro Series at the seventh annual O-Fan Day. The series — ArkPro, ArkPro Ultra, and ArkPro Lite — features a sleek flat-body design with multi-tool versatility and industry-first innovations, setting a new standard for everyday carry lighting. It will debut in Europe at IFA Berlin 2025, showcasing Olight’s lighting innovations worldwide.

ArkPro Series
ArkPro Series

Rethink Light: 4 Sources, Endless Versatility

The ultimate 4-in-1 EDC flashlight, the ArkPro features Pure Flood, spotlight, UV, and green laser. It delivers up to seven lighting modes, redefining handheld lighting with unmatched versatility for work, play, lifestyle, and gifting.

Among the ArkPro Series’ most groundbreaking innovations is Pure Flood, lighting concept pioneered by Olight and the first in the industry. Unlike conventional beams with glaring hotspots or harsh edges, Pure Flood provides a seamless, boundary-free wash of light that feels as natural as daylight, perfect for camping, workspaces, or city exploration. Smooth and immersive — you might forget you’re holding a flashlight.

The ArkPro Ultra introduces exclusive enhancements with Olight’s self-developed EIP 1 LED, delivering clean light with a Duv below 0.006 at all brightness levels. With 134 lm/W efficiency — 10% higher than other high-output LEDs — it sets a new benchmark for EDC lighting performance.

Reimagine Style: Innovative Design and Collectible Appeal

Olight flashlights have long turned utility into artistry, and the ArkPro Series advances this with the industry-first dual-tone Silver Graphite finish on a flat, unibody aluminum design — seamless, robust, and heat-efficient.

World-class industrial design extends to every detail: the ArkPro Series features precision laser-etched indicators and a smooth rotary selector, while micro-perforated dual-color LED indicators set a new benchmark for functional aesthetics.

The ArkPro Ultra elevates design to a dynamic experience with ArkBeat, a subtle breathing-pulse light that shifts color over time, transforming a high-performance tool into a living, collectible companion. Lightweight, elegant, and personalized, making it a standout choice for EDC enthusiasts and a perfect gift.

Everyday Versatility: Performance Meets Lifestyle

“The ArkPro Series sets a new standard for handheld lighting, merging advanced photonics with aerospace-grade materials and sleek design,” said Mavis Xiao, CMO of Olight. “From outdoor freedom to urban confidence, ArkPro is more than a tool — it’s a companion that brightens every journey. Each beam delivers more than light — it carries imagination, style, and inspires a new way of living.”

Full specifications can be found at OLIGHT® | Global Leader in Portable Lighting Industry- Olight.

About Olight

Founded in 2007, Olight is a global innovator in portable lighting, offering a diverse range of pioneering, high-tech products for EDC, outdoor, home and garden, tactical use, and more. With over 1,200 patents and accolades from the iF Design and Red Dot Awards, Olight’s global reach extends to over 100 countries. In 2024, Olight unveiled the world’s first flashlight experience store in Las Vegas, boldly reaffirming its commitment to driving the industry forward.

Media Contact: pr@olight.com 

LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased

HONG KONG, Aug. 30, 2025 /PRNewswire/ — LifeTech Scientific Corporation (“LifeTech” or the “Company”, together with its subsidiaries, the “Group”, stock code: 1302.HK), a medical device company specializing in minimally invasive interventional solutions for cardio-cerebrovascular and peripheral vascular diseases, today announced its unaudited consolidated results for the six months ended 30 June 2025 (the “Reporting Period”).

Revenue Growth: The Group achieved revenue of approximately RMB676.7 million during the Reporting Period, representing a year-on-year increase of approximately 3.7%.

Stable Profitability: Gross profit was approximately RMB497.8 million. Excluding certain non-recurring items[1], net profit attributable to owners of the Company was approximately RMB238.5 million, representing a year-on-year increase of approximately 2.1%.

Strong Cash Position: As at 30 June 2025, the Group’s cash and cash equivalents amounted to approximately RMB782.6 million, representing an increase of approximately 17.5% compared with 31 December 2024.

Note [1]: Such non-recurring items include (i) the other gains arising from financial assets at fair value through profit or loss (“FVTPL”); and (ii) the share-based payment expenses.

Increase in Both Domestic and Overseas Sales

In the first half of 2025, the Group continued to implement a proactive and prudent development strategy, with a strong focus on addressing unmet clinical needs worldwide. By leveraging its synergies in branding, intellectual property, distribution, clinical registration, and global operations, the Group strengthened its long-term growth fundamentals and achieved sales growth in both domestic and overseas markets, driven by an expanding portfolio of innovative products and professional academic services.

China’s mainland remained the foundation and largest market of the Group, where the sales generated accounted for approximately 74.1% of the total revenue of the Group during the Reporting Period. The Group continued to deepen its presence in the mainland China market, achieving a sales increase of approximately 2.2% year-on-year in the first half of 2025.

Meanwhile, overseas business maintained its upward momentum. Benefiting from proactive expansion and effective marketing strategies, the Group’s overseas sales grew by approximately 8.0% year-on-year. Asia (excluding China’s mainland) and Europe were the two largest overseas markets of the Group, where the sales generated accounted for approximately 11.4% and 11.0%, respectively, of the total revenue.

Core Business Demonstrated Resilience

The Group currently has three main product lines, covering the Structural Heart Diseases (SHD) business, the Peripheral Vascular Diseases (PVD) business and the Cardiac Pacing and Electrophysiology (CPE) business.

The revenue of the Group was approximately RMB676.7 million during the Reporting Period, representing a year-on-year growth of approximately 3.7%. The revenue increase was primarily driven by the sales increase of stent grafts and left atrial appendage (LAA) occluders, which rose by approximately 9.6% and 14.7% year-on-year, respectively.

SHD Business
The Group has established a diversified product portfolio in the SHD business, mainly including LAA occluders and three generations of congenital heart diseases occluders, aiming to address various market demands through differentiated product strategies.

During the Reporting Period, the sales contributed by the SHD business were approximately RMB271.5 million, representing a year-on-year increase of approximately 0.1%. Continuous technological innovation and product upgrades will further enrich the Group’s SHD product portfolio and enhance its global sales layout.

PVD Business
The Group is committed to providing patients worldwide with technology-leading systematic and comprehensive interventional medical devices solutions of PVD. The products offered by the Group in the PVD business mainly include vena cava filters, thoracic aortic stent grafts, abdominal aortic stent grafts, iliac artery bifurcation stent grafts, aortic stent graft systems and aortic arch stent graft systems.

During the Reporting Period, the sales contributed by the PVD business were approximately RMB391.7 million, representing a year-on-year growth of approximately 2.9%.

CPE Business
The Company is the first manufacturer in China that has a complete product portfolio of domestic implantable cardiac pacemakers with international-level technology and functions.

During the Reporting Period, the sales contributed by the CPE business were approximately RMB13.5 million, representing a significant year-on-year growth of approximately 1,400.0%.

R&D and Commercialization Progress

The Group is committed to independent innovation, aiming to provide medical devices that deliver exceptional clinical value to physicians and patients while enhancing its long-term competitiveness.

In the first half of 2025, the R&D investment (including capitalized expenditure) of the Group amounted to approximately RMB156.0 million, leading to the following key milestones:

  • Aortic Stent Graft System (consists of the Ankura™ Pro Aortic Stent Graft System and Longuette™ Aortic Branch Stent Graft System), Aortic Arch Stent Graft System (consists of the Ankura™ Plus Aortic Arch Stent Graft System and CSkirt™ Aortic Arch Branch Stent Graft System), Peripheral Balloon Dilatation Catheter (Large diameter), Yoscop™ Multi-loop Snare System and SteerEase™-m Introducer have obtained the National Medical Products Administration (“NMPA”) certification;
  • IrisFit™ PFO Occluder and SteerEase™ Introducer have obtained the CE MDR (Medical Device Regulation) certification. Such products have previously obtained the CE MDD (Medical Device Directive) certification;
  • Thoracoabdominal Artery Stent Graft System (consists of the G-Branch™ Thoracoabdominal Aortic Stent Graft System, SilverFlow™ PV Peripheral Vascular Stent Graft System and Aortic Extension Stent Graft System) and Iliac Bifurcation Device (consists of the G-iliac™ Pro Iliac Bifurcation Stent Graft System and SilverFlow™ Pro Internal Iliac Stent Graft System), etc. are pending registration approval in China;
  • Aortic Stent Graft System (consists of the Ankura™ Pro Aortic Stent Graft System and Longuette™ Aortic Branch Stent Graft System), Fitaya™ Vena Cava Filter System, Futhrough™ Stent Graft Balloon Catheter, Yuranos™ Abdominal Aortic Stent Graft System and G-iliac™ Iliac Bifurcation Device are pending registration approval of CE certification;
  • Concave Supra-arch Branched Stent-Graft System, X-Clip™ Mitral Valve Clip System and Aortic Arch Single Branch Stent Graft System (consists of the Aortic Arch Stent Graft System and Aortic Branch Stent Graft System) are currently at the stage of pre-registration clinical enrollment in China;
  • Cera™ PFO Occluder has completed pre-marketing clinical enrollment and is currently under clinical follow-up in China;
  • IBS Titan™ Sirolimus-Eluting Iron Bioresorbable Peripheral Scaffold System is currently at the stage of clinical enrollment in China and in Europe, and its CE registration application has been submitted; and
  • IBS™ Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System has successfully completed the five-year follow-up of the phase I clinical study and the two-year follow-up of the phase II and III clinical study, further confirming its safety and efficacy. Additionally, its CE and NMPA registration application have been submitted.

Intellectual Property Rights

Intellectual property is an internal driving force to improve our core competitiveness in the medical device market. As at 30 June 2025, the Group had filed a total of 2,464 valid patent applications worldwide, of which 1,123 patents had been granted.

Strategic Collaboration to Enter Electrophysiology Market

On 6 June 2025, the Company, through its wholly-owned subsidiary LifeTech Shenzhen, entered into a series of agreements to invest RMB150.0 million in Affector Medtech (Suzhou) Ltd., (“Affector Medtech”), a high-tech company specializing in electrophysiology and innovative medical devices.

The investment will be carried out in stages, subject to the achievement of certain milestones as set out in the investment agreement. As at the date of the Group’s 2025 interim results announcement, the first stage of the investment has been completed, and Lifetech Shenzhen has acquired a 22.22% equity interest in Affector Medtech. After completion of all stages of the investment, Lifetech Shenzhen will be entitled to 30% of the equity interest in Affector Medtech.

The two parties will focus on the research, development, and commercialization of innovative products and advanced technologies in the field of cardiac electrophysiology, accelerating global breakthroughs in domestically innovated products in cardiac electrophysiology.

The Chairman and CEO of LifeTech, Mr. XIE Yuehui Said:

In the first half of 2025, through our continuous efforts in R&D, channel expansion, production quality control, and internal management, our market foundation has been further strengthened, our globalization process has deepened, and the clinical translation of our product R&D has achieved milestones, demonstrating our strong business resilience. At the same time, the strategic investment in Affector Medtech has opened up vast opportunities in the high-growth electrophysiology market, which will further expand our growth potential with significant synergistic effects.

Guided by our two core development strategies of “innovation” and “internationalization”, we will continuously stimulate our business vitality in the global market and accelerate product development alongside the clinical application of new technologies to benefit more patients worldwide. Leveraging our strong technological capabilities and differentiated portfolio of innovative products, we are poised to capture a larger global market share and further solidify our industry leadership.

Meanwhile, we will strategically position ourselves to capture new growth opportunities worldwide, continuously enhance our resource integration capabilities, strengthen internal and external collaboration, and maintain a prudent yet efficient business operation and capital allocation strategy to advance the company toward higher-quality sustainable development and create long-term value for patients, healthcare providers, shareholders, and all other stakeholders.

About LifeTech Scientific Corporation

Established in 1999 in Shenzhen, China, LifeTech Scientific Corporation (Stock Code: 1302.HK) specializes in the R&D, manufacturing, and sales of minimally invasive interventional medical devices for the treatment of cardio-cerebrovascular and peripheral vascular diseases. The Company offers innovative solutions for structural heart diseases, peripheral vascular diseases, bradycardia, and neurovascular conditions. It also possesses the world’s first innovative iron-based bioabsorbable material technology platform.

Guided by the core strategy of “innovation” and “internationalization”, LifeTech maintains a leading market position for its key products in the home country and has established 7 subsidiaries overseas, extending its sales network to nearly 120 countries and regions worldwide.

 

Jacobio Pharma Announces 2025 Interim Results

BEIJING and SHANGHAI and BOSTON, Aug. 30, 2025 /PRNewswire/ — Jacobio Pharma (1167.HK) today announced its interim results for the six months ended June 30, 2025.

During the reporting period, the Company achieved revenue of RMB45.7 million, representing a 100% increase compared with the same period in 2024. Research and development (R&D) expenses amounted to  RMB93.2 million. The net loss for the first half of 2025 was RMB59.0 million,  narrowing by 65.1% compared with the same period in 2024. As of June 30, 2025, Jacobio maintained cash and bank balances, and investments in capital protected structure deposits, totaling RMB1,07billion, along with RMB270 million bank credit available which provides sufficient and stable liquidity to support our R&D activities.

Dr. Yinxiang Wang, Chairman and Chief Executive Officer of Jacobio, said: “In the first half of 2025, we reached an important milestone with the  approval and launch of Glecirasib in China. Through our collaboration with business partners, we significantly alleviated the pressure of R&D investment, enabling the Company to focus resources on advancing our pan-KRAS inhibitor and ADC pipeline. Looking forward, we  remain committed  to a transformative innovation  strategy, working hand in hand with global partners to accelerate the development of breakthrough therapies and deliver benefits to more cancer patients.”

Accelerated Progress in Core Programs

JAB-23E73 (pan-KRAS inhibitor):

  • The dose-escalation portion of the phase I trials are onging in China and the U.S, respectively.
  • Safety profile: low incidence of skin toxicity (rash observed in 10%, all Grade 1) no Grade ≥3 liver toxicity reported to date.
  • Favorable PK with predicted exposure.
  • Multiple partial responses have been observed to date.
  • Preclinical data to be presented at the AACR-NCI-EORTC International Conference in October 2025.
  • Phase I results readout expected in the first half of 2026.

JAB-BX600 (First-in-class EGFR-KRAS G12Di ADC):

  • This program uses a highly potent KRAS G12D inhibitor as the payload.
  • The candidate demonstrates picomolar (pM)-level cellular activity, compared with nanomolar (nM) typically achieved by oral small molecules.
  • Unlike oral small molecules usually achieve tumor drug concentrations 1–10x higher than plasma levels, the JAB-BX 600 delivers a KRAS G12D inhibitor at 1,000 x higher in tumor, resulting in a substantially wider therapeutic window.
  • The KRAS G12D inhibitor and EGFR antibody have synergistic effect and durable anti-tumor activity.
  • IND submission planned for the second half of 2026.

Glecirasib (JAB-21822, KRAS G12C inhibitor):

  • Approved by China’s NMPA in May 2025 for ≥2L KRAS G12C mutant NSCLC, successfully launched in China.
  • Triggered a RMB50 million milestone payment in addition to the RMB200 million upfront received in 2024.
  • The full second-line NSCLC dataset has been published in Nature Medicine (Impact Factor: 50).
  • Phase I/II data for the combination with SHP2 inhibitor has been accepted by a top-tier academic journal, with publication expected in H2 2025.

Sitneprotafib (JAB-3312, SHP2 inhibitor):

  • Ongoing Phase III registration trial in combination with Glecirasib as first-line NSCLC treatment in China.
  • Translational research published in Clinical Cancer Research (Impact Factor: 10.2), demonstrating significant synergy with Glecirasib.

JAB-BX467 (HER2-STING iADC):

  • A HER2-targeted ADC carrying a STING agonist, designed to convert “cold tumors” into “hot tumors” and address the 70% of patients unresponsive to PD-1 inhibitors.
  • Currently in IND-enabling stage, with IND filing planned for H2 2026.

 

Ingdan, Inc. (400.HK) Announces 2025 Interim Results


Highlights of the Interim Results for the Six Months Ended June 30, 2025:

  • Benefiting from the sustained growth in AI computing power demand, the demand for chips has grown significantly across related industries, driving the Group’s revenue up by approximately 54.5% year-on-year to RMB6,676.5 million.
  • The Group recorded a gross profit of approximately RMB585.9 million, and a net profit of approximately RMB190.0 million. Profit attributable to equity shareholders of the Company was approximately RMB132.1 million, representing an increase of approximately 17.2% year-on-year.
  • Through deep collaboration with Huawei, and leveraging the Ascend 910 chip, Ingdan launched the DeepSeek all-in-one workstation to address the core computing power needs of scientific researchers. Ingdan simultaneously maintained strategic focus on two-wheeler battery cloud services, promoting business diversification.

HONG KONG SAR – Media OutReach Newswire – 29 August 2025 – Ingdan, Inc. (“Ingdan, Inc.” or the “Company”, stock code: 400.HK; with its subsidiaries (the “Group”)) – an application solution platform based upon artificial intelligence (“AI”) chips, with its core businesses “Comtech” and “Ingdan” – announces its unaudited interim results for the six months ended June 30, 2025 (the “First Half of 2025” or the “Period”).

Financial Highlights for the First Half of 2025

During the Period, benefiting from continued strong demand for AI computing power and growing demand for chips from industries related to AI technology, the Group recorded revenue of approximately RMB6,676.5 million, representing an increase of approximately 54.5% as compared to approximately RMB4,321.4 million for the corresponding period in 2024. Gross profit was approximately RMB585.9 million, representing an increase of approximately 28.0% year-on-year, primarily due to the increase in revenue. Profit from operations was approximately RMB275.6 million, representing an increase of approximately 20.8% year-on-year. Profit attributable to equity shareholders of the Company was approximately RMB132.1 million, a year-on-year growth of 17.2%.

As of June 30, 2025, the Company’s cash and bank balances (including pledged deposits) totalled approximately RMB1,626.8 million; bank loans were RMB2,561.2 million; the inventory value was RMB4,877.3 million; the number of basic ordinary shares issued by the Group was 1,644,262,732, and the weighted average number of ordinary shares of diluted earnings per share was 1,544,335,000.

Business Review

During the Period, with deep insights into chip characteristics upstream and industry needs downstream, the Group developed mature application solutions for frontier sectors such as robotics, auto pilot, and the low-altitude economy, helping customers lower their technical barriers and accelerating product innovation. The Group created additional value from “chip selection” to “chip application”, providing “ready-to-use” core technology modules. The modules have significantly shortened customers’ R&D cycles, allowing them to focus on the differentiated innovation of their applications, and to capture early opportunities in the market. Meanwhile, the Group deeply integrated AI technology into its internal operations, achieving intelligent upgrades across our core business processes from marketing and customer acquisition, to supply chain management, which has so far effectively improved operational efficiency.

In terms of the business model, the Group has established a unique closed-loop business model and accomplished a strategic evolution from “chip selling” to “technology integration”. The Group provides customers with efficient supply chain services, in-depth technical solutions, and customized products.

The Group leverages its industry ecosystem to integrate transaction data from all resources, including chips, software, and professional services, empowering the entire value chain both upstream and downstream. Additionally, the Group is providing customized solutions to downstream clients, while providing market demand data to upstream chip suppliers, forming a highly efficient and unique closed-loop business model. This model effectively strengthens our customer loyalty and builds a solid competitive barrier, making it a core driver of the Group’s sustainable development.

Comtech: Advancing AI Computing Power Supply Chain, Comtech Drive Innovation and Operational Excellence

As a core supplier in the AI computing power supply chain, Comtech serves a broad spectrum of sectors, including computing centers, data centers, AI servers, AI switch networking products, optical modules and a wide range of AI applications. Comtech works closely with global leading chip manufacturers and has been an agent for the products of over 80 core chip companies, including Nvidia, Xilinx, Intel, AMD, ST, and other well-known international manufacturers, as well as numerous domestic chip makers.

With years of successful business operations, Comtech has accumulated extensive application technology experience and industrial resources, enabling it to provide chip application technology solutions and supply chain management services to tens of thousands of customers downstream of the innovation industry. At the same time, with the help of proprietary AI technology, LLMs, and professional knowledge bases, Comtech is providing intelligent and automated solutions in the areas of chip selection, hardware design, software development, and system integration. By utilizing AI technology and big data analysis, Comtech has achieved intelligent management of the supply chain, significantly enhanced operational efficiency while reduced costs. Additionally, Comtech holds a number of proprietary intellectual properties, giving it a competitive advantage in the fields of AI chip application and intelligent supply chain.

In addition, the Group has applied to the Shenzhen Bureau of the China Securities Regulatory Commission for pre-listing guidance regarding the proposed spin-off and proposed A-share listing of Comtech. The application has been accepted on the record. Upon completion of the Proposed Spin-off and Proposed A-share Listing, the Group will remain the ultimate controlling shareholder of Comtech, and its results will continue to be consolidated into the Group, being expected to generate long-term growth for the Group’s business.

Ingdan: Targeting the New Energy Industry, Ingdan Academy Empowers the Chip Industry with AI and Digital Solutions

Bolstered by supportive national policies, the scientific research sector has increasing need for domestic computing power. Ingdan has seized the opportunity, and expanded its presence by providing high-performance adaptable hardware and dedicated domestic solutions, along with comprehensive, lifecycle technical maintenance. Ingdan has also integrated “hardware + software + service” into a closed-loop, one-stop service that fully meets our customers’ needs. Meanwhile, through deep collaboration with Huawei and leveraging the Ascend 910 chip, Ingdan launched the DeepSeek all-in-one workstation to address the core computing power needs of scientific researchers. With the growth of Huawei’s Ascend ecosystem, Ingdan will increase its focus on scientific research customers to quickly capture market opportunities in the short term; then leverage this foundation to expand into the broader enterprise market mid-term; and finally, achieve sustainable business growth through deep integration into the industry chain via joint R&D long-term.

Ingdan also focuses on the new energy industry, dedicating efforts to developing the industry for two-wheeler battery replacement and re-utilization, as well as building a reliable asset management platform for traceable lithium battery life-cycle data. Ingdan provides customized solutions for two-wheeler battery replacement, power re-utilization, and energy storage. Ingdan has strategically focused on two-wheeler battery cloud services, aiming to capture the market trend of new energy smart battery clouds. This supports the Group in achieving sustainable profit growth and contributing to advancing product standardisation in China’s two-wheeler battery-swapping industry.

Based on the Group’s resources and technological strengths in the chip industry, Ingdan Academy provides technical services and talent training for the industry. Through technical training, Ingdan Academy assisted upstream AI chip manufacturers in promoting their products and technologies in the market, while growing AI technical talents to help downstream AI application companies to swiftly adopt the latest AI technologies and products, and enhance enterprises’ AI capabilities. Furthermore, Ingdan Academy provides enterprises with locally deployed AI LLM application solutions, and helps enterprises achieve multidisciplinary AI digital transformations. To date, Ingdan Academy has successfully trained over 8,000 chip application engineers. Through talent training and technical support, Ingdan Academy will support Shenzhen as it becomes a leading chip application industry hub in China and globally, making a greater contribution to the development of the national chip industry.

Future Prospects

Mr. Jeffrey Kang, CEO of Ingdan, Inc., said, “During the Period, we successfully completed our strategic upgrade from a chip trading platform to a technology integration platform, underpinned by robust performance. During this transition, we established an efficient ‘customer acquisition-engagement-conversion’ business closed-loop, enabling us to serve tens of thousands of innovative enterprises. Our core competitiveness has evolved beyond the confines of a single business, demonstrating the synergistic strengths of our entire system. Moving forward, we will continue to leverage ‘infrastructure + value-added services’ as our dual engines, transforming data resources into strategic assets. This will further solidify our competitive moat as we progressively become a leading technology service platform for global innovative enterprises, generating long-term and sustainable value for our shareholders.”

Caution Statement

The information contained in this document has not been independently verified. No representation, warranty or undertaking, express or implied, is made by the Company or any of its affiliates, advisers or representatives as to, and no reliance should be placed on the fairness, accuracy, completeness or correctness of such information, or opinions presented or contained herein. The information contained in this document should be considered in the context of the circumstances prevailing at the time, is subject to change without notice and the Company makes no undertaking to update the information in this document to reflect any developments that occur after the date of the presentation. It is not the Company’s intention to provide, and you may not rely on these materials as providing, a complete or comprehensive analysis of the Company, or its financial or trading position or prospects. Neither of the Company nor any of its affiliates, advisers or representatives accept any responsibility or have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any use of this document or its contents or otherwise arising in connection with this document.

This document may contain statements that reflect the Company’s current intent, beliefs, and expectations about the future as of the respective dates indicated herein. These forward-looking statements do not guarantee future performance and are based on a number of assumptions about the Company’s operations and factors beyond the Company’s control and are subject to significant risks and uncertainties, and accordingly, actual results may differ materially from those described in these forward-looking statements. Neither the Company nor any of its affiliates, advisers or representatives has any obligation, nor do they undertake, to update these forward-looking statements for any events or developments including the occurrence of unanticipated events that occur subsequent to such dates.

– End –

About Ingdan, Inc.

Ingdan, Inc. (stock code: 400.HK) is an innovative technology services platform conglomerate, connecting upstream chip technology with the needs of downstream innovation enterprises. Through proprietary artificial intelligence (AI) technology, large language models (“LLMs”), and specialized industry knowledge bases, the Group provides our customers with the cutting-edge of chip application technology solutions, and efficient supply chain management services. Headquartered in Shenzhen, with offices and branches across major cities in China, including Hong Kong, Shanghai, Beijing, Wuhan, Chengdu, Nanjing, Hangzhou, and Xi’an, as well as overseas branches in Singapore and Japan. The Group’s core businesses are Comtech (“Comtech”), a technology services platform for the chip industry, and Ingdan (“Ingdan”), a platform providing Artificial Intelligence of Things (AIoT) technology and services.

For further information, please refer to the Company’s website at www.ingdangroup.com
Hashtag: #Ingdan

The issuer is solely responsible for the content of this announcement.

/C O R R E C T I O N — METALTECH & AUTOMEX/

In the news release, AUTOMEX PENANG 2025 LAUNCHES, PIVOTING MALAYSIA’S MANUFACTURING SECTOR TOWARD INDUSTRY 4.0 LEADERSHIP, issued 28-Aug-2025 by METALTECH & AUTOMEX over PR Newswire, we are advised by the company that the 9th paragraph, 2nd sentence, should read “The press conference was attended by YB Jagdeep Singh Deo, Penang Deputy Chief Minister II, Dato’ Seri Wong Siew Hai, President, Malaysia Semiconductor Industry Association (MSIA), Ir. Johnson Tan, President, Malaysia Automation Technology Association (MATA), Geonice Chong, Deputy Event Director of AUTOMEX Penang and representatives from the Penang Convention & Exhibition Bureau (PCEB).” rather than “The press conference was attended by YB Jagdeep Singh Deo, Penang Deputy Chief Minister II, Andrew Chan, Executive Director, Malaysia Semiconductor Industry Association (MSIA), Ir. Johnson Tan, President, Malaysia Automation Technology Association (MATA), Geonice Chong, Deputy Event Director of AUTOMEX Penang and representatives from the Penang Convention & Exhibition Bureau (PCEB).” as originally issued inadvertently. The complete, corrected release follows:

AUTOMEX PENANG 2025 LAUNCHES, PIVOTING MALAYSIA’S MANUFACTURING SECTOR TOWARD INDUSTRY 4.0 LEADERSHIP

Penang’s “Silicon Valley of the East” to Host Premier Automation and Semiconductor Showcase, Driving Advanced Manufacturing and Global Supply Chain Integration

GEORGE TOWN, Malaysia, Aug. 28, 2025 /PRNewswire/ — AUTOMEX, Malaysia’s leading exhibition for automation and manufacturing technology, is set to make its highly anticipated debut in Penang from 4–6 November 2025 at the Setia SPICE Convention Centre.  The strategic expansion marks a major milestone for AUTOMEX. Building on its 14-year co-location with METALTECH in Kuala Lumpur and nearly three decades of driving industrial innovation nationwide, AUTOMEX is now bringing its focus to Penang – one of Southeast Asia’s most vital industrial corridors.

AUTOMEX Penang Press Conference held at KOMTAR with a special appearance by Penang Deputy Chief Minister II, YB Jagdeep Singh Deo
AUTOMEX Penang Press Conference held at KOMTAR with a special appearance by Penang Deputy Chief Minister II, YB Jagdeep Singh Deo

Recognised globally as the “Silicon Valley of the East,” Penang is home to a powerhouse ecosystem of over 300 multinational corporations and thousands of SMEs. AUTOMEX Penang will directly serve this northern manufacturing hub, showcasing the future of industrial innovation and solidifying Malaysia’s position in the global supply chain.

The inaugural event is expected to feature over 300 exhibitors and attract more than 5,000 trade visitors, offering a dynamic platform for forging partnerships, accelerating technology adoption, and driving economic growth.

AUTOMEX Penang 2025 will showcase breakthrough technologies in automation, next-generation robotics, artificial intelligence, Internet of Things (IoT) solutions, precision CNC machinery, and sustainable manufacturing. The exhibition is designed to empower manufacturers, engineers, and entrepreneurs to discover transformative solutions, forge supplier relationships, and establish cross-border partnerships that will define the future of manufacturing.

A landmark feature of this year’s event is the strategic partnership with the Malaysia Semiconductor Industry Association (MSIA). AUTOMEX Penang will co-host the prestigious Silicon Malaysia Forum (formerly the National E&E Forum), bringing together global leaders and innovators in the semiconductor sector. This strategic partnership will deepen industry integration and foster technological cooperation across the entire value chain.

“The semiconductor industry is the backbone of Penang’s economy and central to Malaysia’s competitiveness,” said Geonice Chong, Deputy Event Director of AUTOMEX Penang. “By co-hosting the Silicon Malaysia Forum at AUTOMEX Penang, we are creating a world-class platform that connects thought leaders, innovators, and investors across the E&E ecosystem. This will help Malaysia move further up the value chain into design, R&D, and advanced manufacturing, while reinforcing our place in the global semiconductor landscape.”

Penang is a vital hub for outsourced semiconductor assembly and test (OSAT) and home to many of the world’s leading technology companies. Its robust ecosystem of multinationals and SMEs contributes significantly to the global supply chain – underscoring its importance as Malaysia’s high-tech engine.

“For nearly three decades, METALTECH and AUTOMEX have championed innovation in Malaysia’s manufacturing sector. With AUTOMEX Penang 2025, we are taking this legacy forward by bringing the event to one of the nation’s most dynamic tech hubs. Our strategic partnership with MSIA positions us to significantly strengthen automation and semiconductor integration, driving Penang’s continued growth while solidifying Malaysia’s leadership position in the global digital economy,” added Geonice Chong.

A press conference was held on 28 August 2025 at the Deputy Chief Minister’s Office in Penang to officially announce the event’s launch. The press conference was attended by YB Jagdeep Singh Deo, Penang Deputy Chief Minister II, Dato’ Seri Wong Siew Hai, President, Malaysia Semiconductor Industry Association (MSIA), Ir. Johnson Tan, President, Malaysia Automation Technology Association (MATA), Geonice Chong, Deputy Event Director of AUTOMEX Penang and representatives from the Penang Convention & Exhibition Bureau (PCEB). Their presence underscores the strong industry-wide support and anticipation for AUTOMEX Penang 2025.

As Malaysia accelerates toward becoming a global Industry 4.0 powerhouse, AUTOMEX Penang 2025 will act as a catalyst for the next phase of industrial transformation in the northern region. By connecting local innovation with global opportunities, the event will position Malaysian manufacturing firmly at the cutting edge of technological advancement.

Seize the opportunity to be at the forefront of this industrial transformation. AUTOMEX Penang 2025 is your gateway to the latest technologies, key industry players, and invaluable business partnerships. Join us at AUTOMEX Penang 2025 from 4–6 November 2025 at the Setia SPICE Convention Centre.

Registration is now open. For more information or to register, please visit www.automex.com.my.

Notes to Editors:
About AUTOMEX Penang
AUTOMEX Penang is Malaysia’s premier exhibition for automation, robotics, and smart manufacturing. Building on a 14-year co-location with METALTECH in Kuala Lumpur, the event expands into PenangMalaysia’s Silicon Valley of the East” and a global hub for semiconductors and advanced manufacturing. The exhibition showcases the latest innovations in robotics, machine vision, artificial intelligence (AI), the Internet of Things (IoT), and sustainable manufacturing solutions – connecting global technology providers with multinational corporations and SMEs. By attending, industry professionals gain access to cutting-edge solutions, strategic partnerships, and insights from thought leaders. AUTOMEX Penang empowers manufacturers, engineers, and decision-makers to accelerate digital transformation, enhance competitiveness, and capture growth opportunities across the global Industry 4.0 value chain.